Weekly shot could replace daily hormone injections for adults
NCT ID NCT01247675
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study tests a new once-weekly growth hormone injection (ACP-001) in adults with growth hormone deficiency. It compares three different doses of the weekly shot against a standard daily growth hormone product over four weeks. The goal is to see if the weekly injection is safe, well-tolerated, and produces similar drug levels in the body as the daily version.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ACP-001 (TransCon hGH)
- What this could lead to
- If successful, this could offer adults with growth hormone deficiency a more convenient once-weekly injection instead of daily shots.
- What could go wrong
- This is an early phase 2 study with only 37 participants over 4 weeks, so results may not apply to all patients. The weekly injection may not work as well as daily treatment or could cause unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital
Aarhus, 8000, Denmark
-
Charité University Hospital Berlin
Berlin, 12203, Germany
-
Karolinska University Hospital
Stockholm, 17176, Sweden
-
University Hospital Genova
Genova, 16132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could growth hormone ease gulf war illness symptoms?
- New weekly shot could help adults with growth hormone deficiency
- Japan study tracks Sogroya's Long-Term safety in severe hormone deficiency
- New growth hormone drug enters first human tests
- New study tracks Sogroya's safety over a decade in growth hormone deficiency
- Weekly shot shows promise for adult growth hormone deficiency in Long-Term trial